More than a handful of different gain-of-function mutations have been reported in the PCSK9 gene which can cause increased degradation of LDLRs, minimising the numbers of receptors on the cell surface and causing monogenic FH. This evidence concerns the gene PCSK9 and familial hyperaldosteronism.